Who owns the RYNFOBEL trademark?

The RYNFOBEL trademark is owned by Meiji Seika Pharma Co., Ltd..

What class is the RYNFOBEL trademark registered in?

The RYNFOBEL trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for RYNFOBEL?

The USPTO serial number for RYNFOBEL is 79384069.

What is the registration number for RYNFOBEL?

RYNFOBEL is registered under USPTO registration number 7510553.

RYNFOBEL - Owned by Meiji Seika Pharma Co., Ltd. - (Class 005)

What to file next

Section 8 declaration of continued use

When: Due between the fifth and sixth anniversary of registration.
Extensions and grace: A six-month grace period follows, with an added per-class fee.
If it is missed: A missed Section 8 cancels the registration, and there is no revival route for it.

How the Section 8 deadline works

General information about USPTO practice, not legal advice. The register is the authority, and a filing that has not yet posted can change what is owed.

Full Goods & Services

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

This description is as filed with the USPTO and defines the scope of trademark protection.

Filing Basis & Declarations

Standard Characters ClaimedTrademark

Status History

16 events

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

May 31, 2025

Code OPNX

NEW REPRESENTATIVE AT IB RECEIVED

May 23, 2025

Code NREP

NEW REPRESENTATIVE AT IB RECEIVED

May 02, 2025

Code NREP

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

Apr 29, 2025

Code OPNR

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Apr 29, 2025

Code OPNS

NEW REPRESENTATIVE AT IB RECEIVED

Apr 25, 2025

Code NREP

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Oct 24, 2024

Code FICR

REGISTERED-PRINCIPAL REGISTER

Sep 24, 2024

Code R.PR

PUBLISHED FOR OPPOSITION

Jul 09, 2024

Code PUBO

NOTICE OF PUBLICATION

Jun 19, 2024

Code NPUB

APPROVED FOR PUB - PRINCIPAL REGISTER

Jun 05, 2024

Code CNSA

ASSIGNED TO EXAMINER

Jun 04, 2024

Code DOCK

APPLICATION FILING RECEIPT MAILED

Dec 26, 2023

Code MAFR

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 20, 2023

Code NWOS

LIMITATION FROM ORIGINAL APPLICATION ENTERED

Dec 13, 2023

Code LIMI

SN ASSIGNED FOR SECT 66A APPL FROM IB

Nov 30, 2023

Code REPR

Other Marks by Meiji Seika Pharma Co., Ltd.

Additional USPTO filings from the same owner.

VYC

VYCRER

79396783

Meiji Seika Pharma Co., Ltd.

REGISTERED

BAC

BACVITY

79396785

Meiji Seika Pharma Co., Ltd.

REGISTERED

LOG

LogoMark

79392270

Meiji Seika Pharma Co., Ltd.

REGISTERED

LOG

LogoMark

79392293

Meiji Seika Pharma Co., Ltd.

REGISTERED

RYNFOBEL

What to file next

Full Goods & Services

Filing Basis & Declarations

Other Marks by Meiji Seika Pharma Co., Ltd.

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Industries

USPTO Deadlines

Compare

Resources

Company

Exceptions